Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 80601-80650 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05381194
BPaL(M) Regimen for the Treatment of MDR/RR-TB
PHASE4
Recruiting
80 participants
Started: Dec 13, 2022 · Completed: Dec 31, 2027
1 condition
13 sponsors
1 location
NCT05677139
A Study for Observing Severe Asthma in Patients Treated With Tezepelumab
N/A
Active, not recruiting
513 participants
Started: Dec 13, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
60 locations
NCT05681351
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
PHASE3
Recruiting
800 participants
Started: Dec 13, 2022 · Completed: Mar 31, 2027
1 condition
1 sponsor
262 locations
NCT05487261
Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction
PHASE4
Recruiting
260 participants
Started: Dec 13, 2022 · Completed: Nov 30, 2025
1 condition
6 sponsors
5 locations
NCT05814952
Safety and Efficacy Study of LX103 Treatment of X-Linked Retinoschisis (XLRS)
NA
Recruiting
12 participants
Started: Dec 13, 2022 · Completed: Aug 31, 2028
1 condition
2 sponsors
1 location
NCT05550298
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
N/A
Recruiting
2,000 participants
Started: Dec 13, 2022 · Completed: Aug 31, 2029
3 conditions
5 sponsors
27 locations
NCT05637801
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011)
NA
Active, not recruiting
670 participants
Started: Dec 13, 2022 · Completed: Jul 31, 2026
35 conditions
1 sponsor
68 locations
NCT05668988
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)
PHASE3
Active, not recruiting
324 participants
Started: Dec 13, 2022 · Completed: Oct 31, 2027
1 condition
1 sponsor
160 locations
NCT05659589
Prognostic Role of the Uremic Toxin Indoxyl Sulfate on Vascular and Cardiac Functions During Acute Kidney Injury
NA
Recruiting
105 participants
Started: Dec 13, 2022 · Completed: Jun 30, 2026
5 conditions
1 sponsor
1 location
NCT05554172
Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders
NA
Recruiting
30 participants
Started: Dec 13, 2022 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT05563051
Kaneka Endovascular Embolization and Protection
NA
Active, not recruiting
164 participants
Started: Dec 13, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
4 locations
NCT05559580
A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms
PHASE2
Active, not recruiting
214 participants
Started: Dec 13, 2022 · Completed: Feb 27, 2026
1 condition
1 sponsor
167 locations
NCT05642091
Role of Ultrasound Elastography in Pleural Effusion
NA
Not yet recruiting
80 participants
Started: Dec 13, 2022 · Completed: Aug 31, 2026
1 condition
1 sponsor
0 locations
NCT05488314
A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer
PHASE1/PHASE2
Active, not recruiting
57 participants
Started: Dec 13, 2022 · Completed: May 21, 2028
1 condition
1 sponsor
78 locations
NCT05624450
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
PHASE3
Recruiting
2,870 participants
Started: Dec 13, 2022 · Completed: Jun 19, 2026
1 condition
1 sponsor
451 locations
NCT06204445
Interindividual Variation in Response to Green Coffee
NA
Active, not recruiting
120 participants
Started: Dec 13, 2022 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT05631249
Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C
PHASE2
Recruiting
40 participants
Started: Dec 13, 2022 · Completed: Dec 12, 2027
2 conditions
1 sponsor
5 locations
NCT05650229
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
PHASE2
Recruiting
180 participants
Started: Dec 13, 2022 · Completed: Nov 30, 2027
1 condition
1 sponsor
23 locations
NCT05565521
UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly
PHASE2
Recruiting
55 participants
Started: Dec 13, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05632068
Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity
PHASE3
Recruiting
100 participants
Started: Dec 13, 2022 · Completed: Jun 30, 2025
3 conditions
1 sponsor
1 location
NCT06250010
Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence
N/A
Recruiting
30 participants
Started: Dec 13, 2022 · Completed: Dec 13, 2025
1 condition
2 sponsors
1 location
NCT05648500
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus
PHASE3
Recruiting
420 participants
Started: Dec 13, 2022 · Completed: May 1, 2027
1 condition
1 sponsor
171 locations
NCT05659576
Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation
PHASE2
Active, not recruiting
142 participants
Started: Dec 13, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
7 locations
NCT05038358
Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance Mechanisms
N/A
Recruiting
60 participants
Started: Dec 12, 2022 · Completed: Dec 31, 2030
2 conditions
1 sponsor
1 location
NCT05555888
The Combination of Immunotherapy and Neoadjuvant Short-course Radiotherapy in Early Rectal Cancer
PHASE2
Recruiting
34 participants
Started: Dec 12, 2022 · Completed: May 1, 2025
1 condition
1 sponsor
1 location
NCT05730699
Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE)
PHASE3
Active, not recruiting
105 participants
Started: Dec 12, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
19 locations
NCT05724446
Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population
PHASE3
Recruiting
60 participants
Started: Dec 12, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05628779
Evaluating Edge-to-edge Transcatheter Tricuspid Valve Repair in Patients With Severe Symptomatic Tricuspid Regurgitation
NA
Enrolling by invitation
150 participants
Started: Dec 12, 2022 · Completed: Nov 1, 2027
4 conditions
2 sponsors
6 locations
NCT05690204
Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.
PHASE2
Active, not recruiting
87 participants
Started: Dec 12, 2022 · Completed: Feb 28, 2025
1 condition
1 sponsor
16 locations
NCT04933136
Radial Artery Occlusion and Dual Artery Hemostasis After Transradial Approach.
N/A
Recruiting
500 participants
Started: Dec 12, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
5 locations
NCT04475393
Carmat Total Artificial Heart As a Bridge to Transplant in Patients with Advanced Heart Failure
NA
Recruiting
52 participants
Started: Dec 12, 2022 · Completed: Apr 30, 2027
1 condition
1 sponsor
10 locations
NCT06417476
Short-course Radiotherapy or Long-course Chemoradiation Followed by MFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer
PHASE2
Recruiting
66 participants
Started: Dec 12, 2022 · Completed: Dec 31, 2025
1 condition
6 sponsors
1 location
NCT05662202
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
PHASE3
Active, not recruiting
172 participants
Started: Dec 12, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
14 locations
NCT05475366
Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures (PACsign)
NA
Recruiting
62 participants
Started: Dec 12, 2022 · Completed: Dec 11, 2028
2 conditions
1 sponsor
6 locations
NCT05589701
Comparing SBRT to CRT in Patients With Spinal Metastases
N/A
Recruiting
100 participants
Started: Dec 12, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05853042
MERITnI - Mindray-hs-cTnI Assay: Analytical and Clinical Evaluation for the Diagnosis and RIsk AssessmenT of Myocardial InfarctIon.
N/A
Active, not recruiting
1,500 participants
Started: Dec 12, 2022 · Completed: May 15, 2025
2 conditions
2 sponsors
1 location
NCT05510622
Uterine Microbiome in Recurrent Pregnancy Loss
N/A
Recruiting
100 participants
Started: Dec 12, 2022 · Completed: May 31, 2026
2 conditions
1 sponsor
2 locations
NCT05645172
Retention Rate of Acalabrutinib in a Non-interventional Setting
N/A
Recruiting
200 participants
Started: Dec 12, 2022 · Completed: Oct 15, 2026
1 condition
1 sponsor
62 locations
NCT05831059
A Sympathetic Ganglion, High-voltage Pulsed Radiofrequency Ablation of Peripheral Neuralgia
NA
Active, not recruiting
60 participants
Started: Dec 12, 2022 · Completed: Dec 15, 2024
1 condition
1 sponsor
1 location
NCT05717972
Effects of Kombucha Intervention on Emotional Distress and Sleep Quality in Breast Cancer Survivors
NA
Recruiting
60 participants
Started: Dec 12, 2022 · Completed: Dec 12, 2025
2 conditions
1 sponsor
1 location
NCT05646901
Involvement of the Gut Microbiota-brain Cross-talk in the Loss of Eating Control
N/A
Recruiting
100 participants
Started: Dec 12, 2022 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT05107349
Cell Signaling, Reinnervation and Metabolism in Kennedy Disease and Amyotrophic Lateral Sclerosis (ALS)
NA
Recruiting
40 participants
Started: Dec 12, 2022 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT05657782
First in Human Phase 1 Ascending Dose Study of PanChol in Healthy Volunteers
PHASE1
Recruiting
53 participants
Started: Dec 12, 2022 · Completed: Dec 1, 2025
2 conditions
1 sponsor
1 location
NCT04884750
Conversational Agent Vaccine Promotion RCT
NA
Recruiting
600 participants
Started: Dec 12, 2022 · Completed: Dec 1, 2025
1 condition
4 sponsors
1 location
NCT06192667
Clinical Performance of Injectable Composite Resins in Class I Cavities
NA
Active, not recruiting
30 participants
Started: Dec 12, 2022 · Completed: Dec 15, 2024
1 condition
1 sponsor
1 location
NCT05619653
Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19
PHASE3
Active, not recruiting
279 participants
Started: Dec 12, 2022 · Completed: Dec 31, 2028
7 conditions
3 sponsors
5 locations
NCT05529316
A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma
PHASE2
Active, not recruiting
174 participants
Started: Dec 12, 2022 · Completed: Feb 29, 2028
1 condition
1 sponsor
51 locations
NCT05254886
Identification and Management of Comorbidities and Extra-intestinal Manifestations in Crohn's Disease: the NEMO Nurse-led Program
NA
Active, not recruiting
198 participants
Started: Dec 12, 2022 · Completed: Jan 1, 2027
1 condition
1 sponsor
2 locations
NCT06325241
Validating the Use of Frailty Measurements to Predict Care & Quality of Life
N/A
Active, not recruiting
123 participants
Started: Dec 12, 2022 · Completed: Mar 31, 2025
1 condition
1 sponsor
1 location
NCT05594927
Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP)
PHASE3
Recruiting
261 participants
Started: Dec 12, 2022 · Completed: Aug 30, 2025
1 condition
1 sponsor
3 locations
Previous
1
More pages
1610
1611
1612
1613
1614
1615
1616
More pages
2369
Next